A carregar...
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma
Lenalidomide is an orally active immunomodulatory drug that has direct antineoplastic activity and indirect effects mediated through multiple types of immune cells found in the tumor microenvironment, including B, T, natural killer (NK), and dendritic cells. Recently, the E3 ubiquitin ligase cereblo...
Na minha lista:
| Publicado no: | J Clin Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5320950/ https://ncbi.nlm.nih.gov/pubmed/26195701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.5363 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|